Skip to main content

Tracing epigenetic evolution of triple-negative breast cancer towards chemo-resistance

Project description

Role of epigenetic evolution in the development of tumour resistance to chemotherapy

Resistance to chemotherapy is a major challenge for the treatment of cancer, with genetic and non-genetic mechanisms contributing to drug resistance. The goal of the EU-funded ChromTrace project is to understand the contribution of epigenetic evolution to chemo-resistance in aggressive triple-negative breast cancer. The researchers will combine lineage tracing and targeted sequencing with a single-cell chromatin profiling approach to reconstruct the dynamics of chromatin features in the course of genetic evolution. Using a live-cell microscopy reporter system, they will evaluate the association of chromatin features with the resistance phenotype to elucidate the mechanisms of epigenetic tumour evolution. The ultimate goal is to apply this new knowledge for the development of therapeutic strategies to control chemo-resistance.

Call for proposal

ERC-2020-STG
See other projects for this call

Funding Scheme

ERC-STG - Starting Grant

Host institution

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Address
Rue Michel Ange 3
75794 Paris
France
Activity type
Other
EU contribution
€ 1 500 000

Beneficiaries (1)

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
France
EU contribution
€ 1 500 000
Address
Rue Michel Ange 3
75794 Paris
Activity type
Other